Geode Capital Management
GTHX

Geode Capital Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,079,645
Closed -$2.46M 4599
2024
Q2
$2.46M Buy
1,079,645
+573,840
+113% +$1.31M ﹤0.01% 3064
2024
Q1
$2.19M Buy
505,805
+45,030
+10% +$195K ﹤0.01% 3080
2023
Q4
$1.41M Buy
460,775
+20,142
+5% +$61.4K ﹤0.01% 3215
2023
Q3
$635K Buy
440,633
+8,981
+2% +$12.9K ﹤0.01% 3509
2023
Q2
$1.07M Sell
431,652
-6,742
-2% -$16.8K ﹤0.01% 3323
2023
Q1
$1.17M Buy
438,394
+83,855
+24% +$225K ﹤0.01% 3271
2022
Q4
$1.93M Buy
354,539
+7,284
+2% +$39.5K ﹤0.01% 3060
2022
Q3
$4.34M Buy
347,255
+5,360
+2% +$66.9K ﹤0.01% 2750
2022
Q2
$1.69M Sell
341,895
-326,245
-49% -$1.61M ﹤0.01% 3175
2022
Q1
$5.08M Sell
668,140
-47,233
-7% -$359K ﹤0.01% 2793
2021
Q4
$7.3M Buy
715,373
+72,270
+11% +$738K ﹤0.01% 2659
2021
Q3
$8.63M Buy
643,103
+32,779
+5% +$440K ﹤0.01% 2567
2021
Q2
$13.4M Buy
610,324
+59,141
+11% +$1.3M ﹤0.01% 2258
2021
Q1
$13.3M Buy
551,183
+67,343
+14% +$1.62M ﹤0.01% 2157
2020
Q4
$8.7M Buy
483,840
+17,712
+4% +$319K ﹤0.01% 2266
2020
Q3
$5.38M Sell
466,128
-1,793
-0.4% -$20.7K ﹤0.01% 2349
2020
Q2
$11.4M Buy
467,921
+10,086
+2% +$245K ﹤0.01% 1862
2020
Q1
$5.05M Buy
457,835
+42,130
+10% +$464K ﹤0.01% 2141
2019
Q4
$11M Buy
415,705
+14,989
+4% +$396K ﹤0.01% 1946
2019
Q3
$9.13M Buy
400,716
+20,116
+5% +$458K ﹤0.01% 2000
2019
Q2
$11.7M Buy
380,600
+68,370
+22% +$2.1M ﹤0.01% 1839
2019
Q1
$5.18M Buy
312,230
+33,167
+12% +$551K ﹤0.01% 2313
2018
Q4
$5.34M Buy
279,063
+26,098
+10% +$500K ﹤0.01% 2181
2018
Q3
$13.2M Buy
252,965
+33,554
+15% +$1.75M ﹤0.01% 1715
2018
Q2
$9.54M Buy
219,411
+33,434
+18% +$1.45M ﹤0.01% 1903
2018
Q1
$6.89M Buy
185,977
+91,611
+97% +$3.39M ﹤0.01% 2036
2017
Q4
$1.87M Buy
94,366
+8,061
+9% +$160K ﹤0.01% 2787
2017
Q3
$2.15M Buy
86,305
+76,085
+744% +$1.89M ﹤0.01% 2697
2017
Q2
$178K Buy
+10,220
New +$178K ﹤0.01% 3729